The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here? (2022)

First Author: Peters R
Attributed to:  MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/alz.12393

PubMed Identifier: 34726352

Publication URI: http://europepmc.org/abstract/MED/34726352

Type: Journal Article/Review

Volume: 18

Parent Publication: Alzheimer's & dementia : the journal of the Alzheimer's Association

Issue: 3

ISSN: 1552-5260